These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 314107)

  • 21. Immune-complexes in malignant skin melanoma: quantitation by three methods, purification, and characterization of their non-tumor related constituents.
    Borzini P; Del Giudice G; Natali S; Serino G; Nembri P; Manca F; Zanussi C
    Boll Ist Sieroter Milan; 1980 Sep; 59(4):366-73. PubMed ID: 7470278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of autoantibodies in the diagnosis of non-A, non-B hepatitis].
    Manns M; Arnold W; Meyer zum Büschenfelde KH
    Leber Magen Darm; 1984 Sep; 14(5):211-5. PubMed ID: 6436603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
    Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
    Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies in myotonic dystrophy.
    Fiorito S; Pocobelli D; Antonini G; Picelli A; Fragola PV; Autore C; Magrini L; Cannata D
    Allerg Immunol (Paris); 1989 Dec; 21(10):377, 379-80. PubMed ID: 2624674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunologic reaction-readiness in malignant melanoma].
    Bickhardt R; Kunze J
    Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological monitoring in patients with malignant melanoma (author's transl)].
    Uhrík J; Jurga L; Hejj F; Cichý A; Dubivská M; Gumanová Z
    Cesk Dermatol; 1980; 55(6):361-67. PubMed ID: 7460038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differentiation of chronic forms of hepatitis by immunological methods].
    Asamer H; Judmaier G; Stühlinger W; Platzer S; Födisch HJ; Spath P; Huber H
    Wien Klin Wochenschr; 1973 Jul; 85(27):485-9. PubMed ID: 4578038
    [No Abstract]   [Full Text] [Related]  

  • 29. [The study of autoantibodies in women with habitual abortion of unknown etiology].
    Li Q; Li H; Tian X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):13-6. PubMed ID: 10682449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum antiretinal antibodies (ARA) in patients with choroidal melanoma--preliminary report].
    Kubicka-Trzaska A; Karska-Basta I; Krukierek-Małec K
    Klin Oczna; 2005; 107(10-12):642-5. PubMed ID: 16619809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis.
    Wasserman J; Glas U; Blomgren H
    Clin Exp Immunol; 1975 Mar; 19(3):417-22. PubMed ID: 1081928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunochemical analysis of two M components (IgG-kappa, IgM-kappa) in a patient with malignant melanoma].
    Okumura J; Yugami H; Fujita S; Mizukami Y; Hashimoto T; Matsubara F; Nakamura S; Migita S
    Rinsho Byori; 1986 Sep; 34(9):1045-8. PubMed ID: 3099036
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of IgA, IgG, and IgM antibodies against Haemophilus parainfluenzae antigens in IgA nephropathy.
    Suzuki S; Gejyo F; Nakatomi Y; Odani S; Sato H; Arakawa M
    Clin Nephrol; 1996 Nov; 46(5):287-95. PubMed ID: 8953116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls.
    Laske C; Zank M; Klein R; Stransky E; Batra A; Buchkremer G; Schott K
    Psychiatry Res; 2008 Feb; 158(1):83-6. PubMed ID: 18096244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis.
    Walton K; Dyer PA; Grennan DM; Haeney M; Harris R
    J Rheumatol; 1985 Apr; 12(2):223-6. PubMed ID: 3875717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in malignant disease.
    Fairley GH
    Br J Haematol; 1972 Sep; 23():Suppl:231-4. PubMed ID: 4539614
    [No Abstract]   [Full Text] [Related]  

  • 38. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
    Gripenberg M; Piirainen H; Linder E
    Scand J Rheumatol; 1981; 10(1):33-7. PubMed ID: 6971488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors.
    Shu S; Nisengard RJ; Hale WL; Beutner EH
    J Lab Clin Med; 1975 Aug; 86(2):259-65. PubMed ID: 1097549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.